Direxion Daily S&P Biotech Bull 3X ETF
LABU
20 hedge funds and large institutions have $18.2M invested in Direxion Daily S&P Biotech Bull 3X ETF in 2020 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 6 closing their positions.
0% more funds holding
Funds holding: 20 → 20 (0)
0% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 6
0.07% less ownership
Funds ownership: 0.3% → 0.24% (-0.07%)
9% less call options, than puts
Call options by funds: $83.6M | Put options by funds: $92.3M
19% less capital invested
Capital invested by funds: $22.5M → $18.2M (-$4.31M)
33% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
+$5.03M |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.99M |
| 3 |
Creative Planning
Overland Park,
Kansas
|
+$378K |
| 4 |
Millennium Management
New York
|
+$261K |
| 5 |
XSC
X-Square Capital
Guaynabo,
Puerto Rico
|
+$237K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$2.85M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$2.4M |
| 3 |
VF
Virtu Financial
New York
|
-$2.36M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$2.02M |
| 5 |
G
Gainplan
Bloomfield Hills,
Michigan
|
-$891K |
LABU Hedge Fund Activity: Q3 2020 in Review
20 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily S&P Biotech Bull 3X ETF (LABU) for Q3 2020, worth a combined $18.2M — down 19% from $22.5M a quarter earlier.
Fund positioning in LABU was balanced in Q3 2020: 6 funds opened new positions, 6 closed out, 4 added to existing stakes and 6 trimmed.
The largest buyer was HRT Financial, adding an estimated $5.03M. The largest seller was Jane Street, cutting an estimated $2.85M.
- 20 institutional investors held Direxion Daily S&P Biotech Bull 3X ETF (LABU) as of Q3 2020, unchanged from Q2 2020.
- Funds reported $18.2M of Direxion Daily S&P Biotech Bull 3X ETF stock for Q3 2020, down 19% quarter-over-quarter.
- 6 funds opened new Direxion Daily S&P Biotech Bull 3X ETF positions in Q3 2020 and 6 closed out, a net change of 0 holders.
- The largest Direxion Daily S&P Biotech Bull 3X ETF buyer in Q3 2020 was HRT Financial, an estimated $5.03M added.
- The largest Direxion Daily S&P Biotech Bull 3X ETF seller in Q3 2020 was Jane Street, an estimated $2.85M sold.
Based on aggregated 13F filings for Q3 2020.